From July 30 to August 1, 2024, the ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) was held at the McCormick Place Convention Center in Chicago, USA. During this event, Snibe showcased not only their full range of chemiluminescence products from the X series but also introduced the latest technologies and products to global customers and partners.

The MAGLUMI X series includes the compact and efficient MAGLUMI X3, designed to maintain high performance within a small footprint. The MAGLUMI X8 features an ultra-high-speed module tailored for high-throughput needs, while the MAGLUMI X6 bridges the gap between the X3 and X8. Another highlight was the Biolumi CX10, an integrated solution combining the high throughput of the MAGLUMI X10 with the efficient biochemical analysis of Biossays C10, offering exceptional throughput in laboratory settings.

Making its debut at the expo, the SATLARS-T8 is the latest addition to Snibe's Total Laboratory Automation Solutions. This powerful system is designed for high throughput and flexibility, featuring intelligent functions and compatibility with multidisciplinary equipment. The SATLARS-T8 promises high efficiency, great flexibility, and easy operation, helping laboratories unlock their full potential.

In addition to these advancements, Snibe also presented unique solutions in biochemistry, as well as the latest equipment for molecular diagnostics and hemostasis testing, to their global partners.

With 29 years of dedication to in vitro diagnostics, Snibe's products are now available in over 155 countries and regions, with more than 30,000 installations worldwide. Snibe remains committed to providing comprehensive services and high-quality products to advance global healthcare. Thank you for joining us at ADLM 2024, and we look forward to seeing you next time!